Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19

被引：11

作者：

Destras, Gregory ^{[1
,2
]}

Assaad, Souad ^{[3
]}

Bal, Antonin ^{[1
]}

Bouscambert-Duchamp, Maude ^{[1
]}

Avrillon, Virginie ^{[3
]}

Simon, Bruno ^{[1
]}

Valette, Martine ^{[1
,2
]}

Blay, Jean-Yves ^{[3
]}

Lina, Bruno ^{[1
,2
]}

Frobert, Emilie ^{[1
,2
]}

Josset, Laurence ^{[1
,2
]}

机构：

[1] Hosp Civils Lyon, Grp Hosp Nord, Lab Virol, Inst Agents Infect,Ctr Natl Reference France Sud, F-69004 Lyon, France

[2] Univ Lyon, Virpath, CIRI, INSERM,U1111,CNRS UMR5308,ENS Lyon,Univ Claude Be, Lyon, France

[3] Ctr Leon Berard, Lyon, France

来源：

LANCET MICROBE | 2021年 / 2卷 / 09期

关键词：

D O I：

10.1016/S2666-5247(21)00189-0

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：424 / 424

页数：1

共 5 条

[1] SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 [J].

Chen, Peter ;

Nirula, Ajay ;

Heller, Barry ;

Gottlieb, Robert L. ;

Boscia, Joseph ;

Morris, Jason ;

Huhn, Gregory ;

Cardona, Jose ;

Mocherla, Bharat ;

Stosor, Valentina ;

Shawa, Imad ;

Adams, Andrew C. ;

Van Naarden, Jacob ;

Custer, Kenneth L. ;

Shen, Lei ;

Durante, Michael ;

Oakley, Gerard ;

Schade, Andrew E. ;

Sabo, Janelle ;

Patel, Dipak R. ;

Klekotka, Paul ;

Skovronsky, Daniel M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) :229-237

[2] Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host [J].

Choi, Bina ;

Choudhary, Manish C. ;

Regan, James ;

Sparks, Jeffrey A. ;

Padera, Robert F. ;

Qiu, Xueting ;

Solomon, Isaac H. ;

Kuo, Hsiao-Hsuan ;

Boucau, Julie ;

Bowman, Kathryn ;

Das Adhikari, U. ;

Winkler, Marisa L. ;

Mueller, Alisa A. ;

Hsu, Tiffany Y. -T. ;

Desjardins, Michael ;

Baden, Lindsey R. ;

Chan, Brian T. ;

Walker, Bruce D. ;

Lichterfeld, Mathias ;

Brigl, Manfred ;

Kwon, Douglas S. ;

Kanjilal, Sanjat ;

Richardson, Eugene T. ;

Jonsson, A. Helena ;

Alter, Galit ;

Barczak, Amy K. ;

Hanage, William P. ;

Yu, Xu G. ;

Gaiha, Gaurav D. ;

Seaman, Michael S. ;

Cernadas, Manuela ;

Li, Jonathan Z. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2291-2293

[3] Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial [J].

Gottlieb, Robert L. ;

Nirula, Ajay ;

Chen, Peter ;

Boscia, Joseph ;

Heller, Barry ;

Morris, Jason ;

Huhn, Gregory ;

Cardona, Jose ;

Mocherla, Bharat ;

Stosor, Valentina ;

Shawa, Imad ;

Kumar, Princy ;

Adams, Andrew C. ;

Van Naarden, Jacob ;

Custer, Kenneth L. ;

Durante, Michael ;

Oakley, Gerard ;

Schade, Andrew E. ;

Holzer, Timothy R. ;

Ebert, Philip J. ;

Higgs, Richard E. ;

Kallewaard, Nicole L. ;

Sabo, Janelle ;

Patel, Dipak R. ;

Klekotka, Paul ;

Shen, Lei ;

Skovronsky, Daniel M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07) :632-644

[4] SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies [J].

Hoffmann, Markus ;

Arora, Prerna ;

Gross, Rudiger ;

Seidel, Alina ;

Hornich, Bojan F. ;

Hahn, Alexander S. ;

Kruger, Nadine ;

Graichen, Luise ;

Hofmann-Winkler, Heike ;

Kempf, Amy ;

Winkler, Martin S. ;

Schulz, Sebastian ;

Jack, Hans-Martin ;

Jahrsdorfer, Bernd ;

Schrezenmeier, Hubert ;

Muller, Martin ;

Kleger, Alexander ;

Munch, Jan ;

Pohlmann, Stefan .

CELL, 2021, 184 (09) :2384-+

[5] Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 [J].

Starr, Tyler N. ;

Greaney, Allison J. ;

Addetia, Amin ;

Hannon, William W. ;

Choudhary, Manish C. ;

Dingens, Adam S. ;

Li, Jonathan Z. ;

Bloom, Jesse D. .

SCIENCE, 2021, 371 (6531) :850-+

← 1 →